The DigiNet project builds on the preliminary work of the national network Genomic Medicine (nNGM) Lung Cancer. In this network, harmonised and quality-assured molecular complex diagnostics, counselling and clinical information based on selective contracts in accordance with § 140a SGB V is carried out throughout Germany in selected network centres, including oncological centres of excellence. The aim of DigiNet is now to develop a digital control instrument that maps the implementation of molecularly controlled therapies over the entire course of the disease and that enables the networking of all treatment partners involved in the breadth of care with the inclusion of the patients. The project is being implemented in two model regions (West: NRW, East: Berlin and Saxony).

Involved Institutions
Uniklinik Köln
Universitätsmedizin Essen
Charité – Universitätsmedizin Berlin
Helios Klinikum Berlin-Buch
Universitätsklinikum Dresden
Berlin Institute of Health
AOK Rheinland/Hamburg
AOK Nordwest
Deutsche Krebsgesellschaft e. V.
Bundesverband für Niedergelassene Hämatologen und Onkologen e. V.
ZielGENau e. V.
Universität Greifswald
Universität zu Köln
FOM – Hochschule für Ökonomie und Management
WIdO – Wissenschaftliches Institut der AOK
OnkoZert GmbH

Innovation Committee of The Federal Joint Committee (G-BA)

1. Oktober 2021 – 30. September 2025

see publications


Dr. med. Martin Utzig
Dr. med. Nora Tabea Sibert